All In MedTech

FDA Clearance Tracker · P980035-S272

ADVISA DR IPG, AT501 DDDRP PACING SYSTEM IPG

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 26, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Mar 26, 2013

Approved

Time to decision

217 days

Received Aug 21, 2012. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P980035-S272
Device name
ADVISA DR IPG, AT501 DDDRP PACING SYSTEM IPG
Applicant location
Mounds View, MN
Received
Aug 21, 2012
Decided
Mar 26, 2013
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P980035

Device type

Device class
Class III

Every decision under product code NVZ

FDA's approval statement

As written in FDA's record.

APPROVAL FOR LABELING UPDATES TO INCORPORATE THE RESULTS OF THE RESPECT POST-APPROVAL STUDY FINAL REPORT, AND ADDITIONAL LABELING UPDATES.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.